Leidos/$LDOS
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Leidos
Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health management, both domestically and internationally. The customers of the company includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in four reportable segments; National Security & Digital, Health & Civil, Commercial & International and Defense Systems. It provides a wide array of scientific, engineering and technical services and solutions across these reportable segments.
- Ticker
- $LDOS
- Sector
- Business services
- Primary listing
- NYSE
- Employees
- 50,000
- Headquarters
- Reston, United States
- Website
- www.leidos.com
Leidos Metrics
BasicAdvanced
$17B
12.27
$11.18
0.54
$1.72
1.25%
Price and volume
Market cap
$17B
Beta
0.54
52-week high
$205.00
52-week low
$98.86
Average daily volume
1.1M
Dividend rate
$1.72
Financial strength
Current ratio
1.599
Quick ratio
1.125
Long term debt to equity
1.253
Total debt to equity
1.256
Dividend payout ratio (TTM)
15.29%
Interest coverage (TTM)
8.82%
Profitability
EBITDA (TTM)
2,411
Gross margin (TTM)
17.63%
Net profit margin (TTM)
7.97%
Operating margin (TTM)
11.84%
Effective tax rate (TTM)
19.65%
Revenue per employee (TTM)
$360,000
Management effectiveness
Return on assets (TTM)
9.08%
Return on equity (TTM)
28.27%
Valuation
Price to earnings (TTM)
12.274
Price to revenue (TTM)
0.964
Price to book
3.24
Price to tangible book (TTM)
-4.88
Price to free cash flow (TTM)
8.757
Free cash flow yield (TTM)
11.42%
Free cash flow per share (TTM)
15.672
Dividend yield (TTM)
1.25%
Forward dividend yield
1.25%
Growth
Revenue change (TTM)
2.67%
Earnings per share change (TTM)
4.66%
3-year revenue growth (CAGR)
5.50%
10-year revenue growth (CAGR)
11.86%
3-year earnings per share growth (CAGR)
118.80%
10-year earnings per share growth (CAGR)
11.26%
3-year dividend per share growth (CAGR)
6.10%
10-year dividend per share growth (CAGR)
2.11%
What the Analysts think about Leidos
Analyst ratings (Buy, Hold, Sell) for Leidos stock.
Analyst projections of the future price of Leidos stock.
Bulls say / Bears say
Third-quarter non-GAAP diluted EPS rose 19% year on year to $3.62, while adjusted EBITDA margin edged up to 13.9%. Leidos credited better programme execution and cost control. (SEC)
New bookings were $5.5 billion, a 1.2 book-to-bill ratio, and funded backlog grew 22% year on year to $11.1 billion. Awards across defence, cyber and air-traffic management provide a solid base of contracted work. (SEC)
Leidos raised its 2026 non-GAAP EPS outlook to $12.50–$12.70 and operating cash-flow guidance to about $1.9 billion. The higher earnings and cash targets offer support despite a lower revenue forecast. (SEC)
Third-quarter revenue of $4.63 billion missed forecasts, and Leidos cut its 2026 revenue range to $18.0–$18.2 billion. Management also said contract delays and decisions that went against it would temper growth into 2027. (Investing.com, SEC)
Health revenue fell 12% year on year and its operating margin dropped to 22.5% from 26.8%. The VBA contract transition adds uncertainty to the segment’s future performance. (SEC, Investing.com)
Management said 2027 is not expected to be a year of bottom-line growth, citing the VBA contract transition. That near-term earnings pause could weigh on investor expectations even if growth resumes later. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 3 Nov 2026.
Leidos Financial Performance
Revenues and expenses
Leidos Earnings Performance
Company profitability
Upcoming events
Leidos News
AllArticlesVideos
Funds containing Leidos
AllUSDGBPEUR
Fund name | Fund size | $LDOS weighting |
|---|---|---|
Vaneck Defense£DFNG | $7.2B | 4.08% |
VanEck Defense€DFEN | $7.2B | 4.08% |
Global X Defence Tech£ARMG | $537M | 2.15% |
Global X Defence Tech$ARMR | $537M | 2.15% |
Invesco Defence Innovation£DFNX | $161M | 1.93% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.